{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:12:00Z","timestamp":1791756720072,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.intimp.2023.110048","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T20:22:59Z","timestamp":1679948579000},"page":"110048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Study on immune status alterations in patients with sepsis"],"prefix":"10.1016","volume":"118","author":[{"given":"Zhiwen","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110048_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2023.110048_b0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.intimp.2023.110048_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence."},{"key":"10.1016\/j.intimp.2023.110048_b0020","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/01.CCM.0000145999.42971.4B","article-title":"Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes","volume":"32","author":"Venet","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.110048_b0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2023.110048_b0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.21037\/atm.2017.09.21","article-title":"Defects in innate and adaptive immunity in patients with sepsis and health care associated infection","volume":"5","author":"Ryan","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.intimp.2023.110048_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40635-022-00471-6","article-title":"T cell dysregulation in inflammatory diseases in ICU","volume":"10","author":"Luperto","year":"2022","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.intimp.2023.110048_b0040","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"MARS Consortium Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit after admission for sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2023.110048_b0045","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/emm.2017.146","article-title":"Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation","volume":"49","author":"Choi","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2023.110048_b0050","doi-asserted-by":"crossref","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","article-title":"Reactivation of multiple viruses in patients with sepsis","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2023.110048_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.586195","article-title":"Severe Altered Immune Status After Burn Injury Is Associated with Bacterial Infection and Septic Shock","volume":"12","author":"Moins-Teisserenc","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110048_b0060","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/cc10332","article-title":"The late phase of sepsis is characterized by an increased microbiological burden and death rate","volume":"15","author":"Otto","year":"2011","journal-title":"Crit. Care."},{"key":"10.1016\/j.intimp.2023.110048_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/jcm8030353","article-title":"Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis","volume":"8","author":"Hohlstein","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110048_b0070","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1401711","article-title":"Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge","volume":"194","author":"Cabrera-Perez","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110048_b0075","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1097\/CCM.0000000000000344","article-title":"Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration","volume":"42","author":"Gu\u00e9rin","year":"2014","journal-title":"Crit. Care. Med."},{"key":"10.1016\/j.intimp.2023.110048_b0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110048_b0085","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.21037\/jtd.2016.03.47","article-title":"Balanced control of both hyper and hypo-inflammatory phases as a new treatment paradigm in sepsis","volume":"8","author":"Tsirigotis","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.intimp.2023.110048_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nbt0308-303","article-title":"What is principal component analysis?","volume":"26","author":"Ringn\u00e9r","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2023.110048_b0095","doi-asserted-by":"crossref","unstructured":"T. D. Martins, J. M. Annichino-Bizzacchi, A. V C. Romano, R. M. Filho, Principal Component Analysis on Recurrent Venous Thromboembolism. Clin. Appl. Thromb. Hemost. 25 (2019) 1076029619895323, https:\/\/doi.org\/10.1177\/1076029619895323.","DOI":"10.1177\/1076029619895323"},{"key":"10.1016\/j.intimp.2023.110048_b0100","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski","year":"2013","journal-title":"Crit. Care Med."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2023.110048_b0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40635-020-00309-z","article-title":"Role of the adaptive immune response in sepsis","volume":"8","author":"Brady","year":"2020","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.intimp.2023.110048_b0110","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fimmu.2020.01364","article-title":"CD4 T cell Responses and the Sepsis-Induced Immunoparalysis State","volume":"11","author":"Martin","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2023.110048_b0115","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2023.110048_b0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/MPA.0000000000000894","article-title":"Increased Circulating CD4+CD25+CD127low\/neg Regulatory T-cells as a Prognostic Biomarker in Acute Pancreatitis","volume":"46","author":"Minkov","year":"2017","journal-title":"Pancreas."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:53:34Z","timestamp":1761587614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923003697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"alternative-id":["S1567576923003697"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110048","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on immune status alterations in patients with sepsis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110048"}}